Clinical Trials Directory

Trials / Completed

CompletedNCT01280253

Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture

Can Biochemical Tests Predict Outcome in Patients With Hip Fracture?

Status
Completed
Phase
Study type
Observational
Enrollment
999 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to identify biochemical predictors of morbidity and mortality in patients suffering from hip fracture. For this purpose blood samples are collected prehospitally or in the emergency department in patients with a suspected hip fracture. During the hospital stay medical history, anesthesiological management recorded. In addition, american society of anesthesiology physiological score (ASA), revised cardiac risk index (RCRI), and POSSUM score is calculated. Morbidity and mortality is recorded " in house", after 30 days, after 4 months and after 1 year. Biochemical predictors of outcome will be evaluated with logistic regression analysis. Biochemical predictors include pro-brain natriuretic peptide, lactate, pro-calcitonin, adrenomedullin, copeptin, cystatin c. The predictive value of the potential markers will be compared to that of ASA, RCRI and POSSUM.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2014-08-01
First posted
2011-01-20
Last updated
2016-11-15

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01280253. Inclusion in this directory is not an endorsement.

Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture (NCT01280253) · Clinical Trials Directory